GlassScriptPhysician profile
Richard Pat Mistretta
NPI 1104806157
$2,168.97
in general payments reported to CMS, 2019-2025
27 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $269 · 2021: $120 · 2022: $210 · 2023: $49.54 · 2024: $246 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $305.68 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Aroa Biosurgery Incorporated | $255.76 | 2019-2020 | |
| Horizon Therapeutics Plc | $245.75 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $224.99 | 2020-2025 | Nuzyra |
| Smith+Nephew, INC. | $155.83 | 2019-2021 | |
| Organogenesis INC. | $152.29 | 2021-2022 | |
| Stryker Corporation | $140.95 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pacira Pharmaceuticals Incorporated | $118.25 | 2019 | |
| Medical Device Business Services, INC. | $109.52 | 2019 | |
| Nevro Corp. | $72.44 | 2022-2024 | Senza |
| Avinger INC. | $56.71 | 2019 | |
| Acumed LLC | $52.71 | 2024 | Acumed, Osteomed |
| Zyla Life Sciences, INC. | $32.12 | 2019 | |
| Osteomed LLC | $31.80 | 2019 | |
| Hydrofera LLC | $30.70 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $30.07 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Grt US Holding, INC. | $24.28 | 2021 | |
| Triad Life Sciences INC. | $19.40 | 2022 | |
| Treace Medical Concepts, INC. | $18.18 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.73 | 2020 | |
| Fidia Pharma USA INC. | $14.34 | 2025 | Triluron, Hymovis |
| Zimvie INC. | $13.20 | 2023 | |
| Medline Industries LP | $12.74 | 2020 | |
| Merck Sharp & Dohme LLC | $12.71 | 2019 | |
| Paragon 28, INC. | $11.95 | 2020 | |
| Reprise Biomedical, INC. | $6.13 | 2024 | Miro3d |
| Orthofix Medical, INC. | $3.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mistretta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.